Trial Profile
A Double Blind, Randomized Placebo Controlled Trial of the Perioperative Use of Solifenacin in the Management of Postoperative Overactive Bladder Symptoms in Patients With Mixed Incontinence Undergoing Suburethral Sling Procedures.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2022
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Mixed incontinence
- Focus Therapeutic Use
- 08 Jun 2022 Status changed from completed to discontinued because Investigator left Cleveland Clinic and absolutely no data is available.
- 08 Feb 2012 Actual patient number is 11 according to ClinicalTrials.gov.
- 08 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.